27 May 2019 --- Consumer interest in cannabidiol (CBD) is booming, with CBD-infused products proliferating at an astounding pace. Whether the cannabis extract has indeed proven its potential as a new consumer staple, or is slated to become another “has-been cure-all in the supplement aisle,” remains to be seen. According to a new Rabobank report, which takes a hard look at the future of this emergent market in the US, questions remain about just how mainstream it can become amid huge legal ambiguity, with the possibility of a crash existing.
